AM
IBER

Ampfield Management’s Ibere Pharmaceuticals IBER Stock Holding History

Ampfield Management’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,542
Closed -$432K – 11
2021
Q3 		$432K Sell
44,542
-1
-0% -$10 0.38% 11
2021
Q2 		$431K Buy
+44,543
New +$433K 0.35% 13

Other funds holding IBER

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Ampfield Management's IBER Position: Q4 2021 in Review

Ampfield Management sold out of Ibere Pharmaceuticals (IBER) in Q4 2021, closing a stake of 44,542 shares — an estimated $432K sold.

Ampfield Management first reported a position in IBER in Q2 2021 and held it in 2 quarters. The position peaked at $432K in Q3 2021. 47 funds tracked by Wall St. Rank hold IBER as of Q4 2021.

  • Ampfield Management reported no remaining Ibere Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Ampfield Management sold 44,542 Ibere Pharmaceuticals shares in Q4 2021, an estimated $432K.
  • Ampfield Management first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Ampfield Management's Ibere Pharmaceuticals position peaked at $432K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q4 2021.

Based on Ampfield Management's 13F filing for Q4 2021, filed 26 Jan 2022.